Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Stem Cell Reports is Scopus-indexed (Q2, CiteScore 5.2), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 2198-7866Verify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: About US$3,990 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Developmental Biology | 32 / 78 | 58th | Q2 |
| Genetics | 152 / 357 | 57th | Q2 |
| Molecular Biology | 220 / 414 | 46th | Q3 |
| Cell Biology | 170 / 289 | 41st | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q2, CiteScore 5.2.
Current Stem Cell Reports is Q2 in Developmental Biology (rank 32 of 78), Q2 in Genetics (rank 152 of 357) and Q3 in Molecular Biology (rank 220 of 414), by CiteScore 2025. It is ranked in 4 subject areas in all.
Current Stem Cell Reports is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.2, which places it in quartile Q2 at the 58th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.606, quartile Q3, with an H-index of 29.
The publisher lists an article processing charge of about US$3,990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Current Stem Cell Reports is published by Springer Science and Business Media Deutschland GmbH. Its ISSN is 2198-7866.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Stem Cell Reports has an h-index of 33 and a 2-year mean of 2.5 citations per paper (OpenAlex). Its Scopus CiteScore is 5.2, quartile Q2. On 2-year citations it ranks #35 of 76 Scopus journals in Developmental Biology.
Current Stem Cell Reports published 10 papers in 2025; its busiest recent year was 2017 with 40. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 75 research articles (2021–2026), authors are most often from United States (60.9%), Germany (6.9%) and United Kingdom (6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.